Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial

Author:

Kudo Masatoshi1,Han Guohong2,Finn Richard S.3,Poon Ronnie T.P.4,Blanc Jean-Frederic5,Yan Lunan6,Yang Jijin7,Lu Ligong8,Tak Won-Young9,Yu Xiaoping10,Lee Joon-Hyeok11,Lin Shi-Ming12,Wu Changping13,Tanwandee Tawesak14,Shao Guoliang15,Walters Ian B.16,Dela Cruz Christine17,Poulart Valerie18,Wang Jian-Hua19

Affiliation:

1. Department of Gastroenterology and Hepatology; Kinki University School of Medicine; Osaka Japan

2. Xijing Hospital Fourth Military Medical University; Xi'an Shaanxi China

3. Geffen School of Medicine at University of California Los Angeles; Los Angeles CA

4. Department of Hepatobiliary and Pancreatic Surgery; University of Hong Kong; Hong Kong S.A.R.

5. Department of Hepato-Gastroenterology; Hospital Saint Andre and University Hospital of Bordeaux; Bordeaux France

6. Liver Transplantation Department; West China Hospital of Sichuan University; Chengdu China

7. Changhai Hospital; Shanghai China

8. Guangdong Provincial People's Hospital; Guangdong China

9. Department of Internal Medicine; Kyungpook National University Hospital; Daegu Republic of Korea

10. Hunan Provincial Tumor Hospital; Changsha Hunan China

11. Division of Gastroenterology; Sungkyunkwan University School of Medicine, and Samsung Medical Center; Seoul Republic of Korea

12. Chang Gung Memorial Hospital; Linkou Branch, Kueishan Shiang Taoyuan Taiwan

13. The First People's Hospital of Changzhou; Changzhou China

14. Faculty of Medicine; Siriraj Hospital, Mahidol University; Bangkok Thailand

15. Zhejiang Cancer Hospital; Hangzhou China

16. Bristol-Myers Squibb; Wallingford CT

17. Bristol-Myers Squibb; Singapore

18. Bristol-Myers Squibb; Braine-l'Alleud Belgium

19. Zhongshan Hospital; Shanghai China

Funder

Bristol-Myers Squibb

Publisher

Wiley

Subject

Hepatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3